FDAMA 114 and the 21st Century Cures Act

By Xcenda

Xcenda presented an educational symposium on FDAMA 114 and the 21st Century Cures Act at ISPOR's 22nd International Meeting in Boston on May 23, 2017. Jay Jackson, PharmD, MPH, moderated a panel of experts to discuss insights from US payers and pharmaceutical manufacturers on the implications of the 21st Century Cures Act on the exchange of HCEI.

Related Content

Finding the Balance in Pharmaceutical Evidence Exchange With Payers and Providers

Jennifer Snow, MPH
August 2017

Manufacturers

Buy-and-bill vs. self-administered: Field services remove barriers across access points

Rod Bryant
Rod Bryant, MS; MarSha Lewers
March 2021

Manufacturers

Checklist: Four things to look for in a field services partner

Inverted color AmerisourceBergen icon
Xcenda
February 2021
xcenda field services working on project